Abstract

Objective: To evaluate the efficacy, complication rates, recurrence, infection, and need for reoperation of the seton technique in the treatment of chronic pilonidal sinus disease.

Methods: A retrospective review was conducted using our hospital’s general surgery database, analyzing patients treated with the seton technique for chronic pilonidal sinus between December 2018 and January 2020. Patients with incomplete records were contacted by phone for verification and included in the study. A total of 30 patients (6 female [20%], 24 male [80%]) were evaluated. The mean age was 26.4 ± 5.2 years (range: 18–39). Seton duration ranged from 16 to 24 weeks (mean: 20 weeks). In three patients (10%), wound closure was not achieved; these cases required skin incision, seton removal, and phenol injection support.

Results: The technique was used in non-complicated cases (>2 cm size, <2 orifices) without a history of recurrence. This minimally invasive approach offered advantages such as low pain, no need for dressing or drainage, >90% cost reduction, and no hospital stay. Additional intervention was required in three cases (10%); the recurrence rate was 6.7%, and the infection rate was 3.3%.

Conclusion: The seton technique is an effective, minimally invasive method for chronic pilonidal sinus disease, similar to fistula treatment principles. Phenol support is recommended to reduce long-term recurrence rates.

Keywords: Pilonidal sinus, seton technique, minimally invasive surgery, recurrence

License

Copyright (c) 2025 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to Cite

1.
Tokoçin M, Gündoğdu A, Şekerci UU. Use of seton in chronic pilonidal sinus disease: a retrospective evaluation. J Trends Med Invest. 2025;1(2):54-7. https://doi.org/10.64512/JTMI.2025.15

References

  1. McCallum I, King PM, Bruce J. Healing by primary versus secondary intention after surgical treatment for pilonidal sinus. Cochrane Database Syst Rev. 2007;(4):CD006213. Published 2007 Oct 17. https://doi.org/10.1002/14651858.CD006213.pub2 DOI: https://doi.org/10.1002/14651858.CD006213.pub2
  2. Gecim IE, Goktug UU, Celasin H. Endoscopic pilonidal sinus treatment combined with crystalized phenol application may prevent recurrence. Dis Colon Rectum. 2017;60(4):405–407. https://doi.org/10.1097/DCR.0000000000000778 DOI: https://doi.org/10.1097/DCR.0000000000000778
  3. El Nagar MM, Shaheen AS. Pilonidal sinus management by seton silac. International Journal of Current Research. 2020;12(5):10727-30.
  4. Dogru O, Camci C, Aygen E, Girgin M, Topuz O. Pilonidal sinus treated with crystallized phenol: an eight-year experience. Dis Colon Rectum. 2004;47(11):1934-1938. https://doi.org/10.1007/s10350-004-0720-y DOI: https://doi.org/10.1007/s10350-004-0720-y
  5. Steel M, Siddiqui S, Brown S. Pilonidal sinus disease: contemporary management and future directions. Colorectal Dis. 2024;26(3):456-465. https://doi.org/10.1097/10.1111/codi.16789